Source: https://www.federalregister.gov/documents/2006/03/16/06-2554/new-animal-drugs-change-of-sponsors-drug-labeler-code
Timestamp: 2018-04-21 21:30:04
Document Index: 801299481

Matched Legal Cases: ['§\u2009510', '§\u2009520', '§\u2009520', '§\u2009520', '§\u2009520', '§\u2009520', '§\u2009520', '§\u2009520', '§\u2009520', '§\u2009520', '§\u2009520', '§\u2009520', '§\u2009522', '§\u2009524', '§\u2009524', '§\u2009510', '§\u2009524', '§\u2009524', '§\u2009524', '§\u2009524', '§\u2009524', '§\u2009510', '§\u2009524', '§\u2009524', '§\u2009524', '§\u2009524', '§\u2009524', '§\u2009524', '§\u2009524', '§\u2009510', '§\u2009529', '§\u2009529']

A Rule by the Food and Drug Administration on 03/16/2006
This rule is effective March 16, 2006.
71 FR 13541
13541-13543 (3 pages)
06-2554
https://www.federalregister.gov/d/06-2554 https://www.federalregister.gov/d/06-2554
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of drug labeler code for Med-Pharmex, Inc.
Charles Eastin, Center for Veterinary Medicine (HFV-210), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-276-9077, e-mail: charles.eastin@fda.hhs.gov.
FDA has found that the animal drug regulations do not reflect the correct drug labeler code for Med-Pharmex, Inc. Accordingly, the agency is amending the regulations in 21 CFR 510.600, 520.1044a, 520.1195, 520.1484, 520.1485, 520.2220a, 520.2345d, 522.900, 524.1044b, 524.1044f, 524.1044g, 524.1193, 524.1443, 524.1580b, 524.1580e, 524.1600a, 524.2481, and 529.1044b to correct this error. In addition, 21 CFR 524.1044b, 524.1044f, 524.1443, and 524.2481 are being revised to reflect a current format.
, 522, 524, and 529
2. Amend § 510.600 in the table in paragraph (c)(1) in the entry for “Med-Pharmex, Inc.” by removing “051259” and by adding in its place “054925”; and in the table in paragraph (c)(2) by removing the entry for “051259” and by
054925 Med-Pharmex, Inc., 2727 Thompson Creek Rd., Pomona, CA 91767-1861
§ 520.1044a
4. In paragraph (b) of § 520.1044a, remove “051259” and add in its place “054925”.
5. In paragraph (b)(2) of § 520.1195, remove “051259” and add in its place “054925”.
§ 520.1484
6. In paragraph (b)(1) of § 520.1484, remove “051259” and add in its place “054925”.
§ 520.1485
7. In paragraph (b) of § 520.1485, remove “051259” and add in its place “054925”.
§ 520.2220a
8. In paragraphs (a)(1) and (a)(2) of § 520.2220a, remove “051259” and add in its place “054925”.
§ 520.2345d
9. In paragraphs (b)(5), (d)(1)(iii), and (d)(2)(iii) of § 520.2345d, remove “051259” and add in its place “054925”.
11. In paragraph (b)(1) of § 522.900, remove “051259” and add in its place “054925”.
13. Revise § 524.1044b to read as follows:
§ 524.1044b
Gentamicin sulfate, betamethasone valerate otic solution.
(a) Specifications. Each milliliter of solution contains gentamicin sulfate equivalent to 3 milligrams (mg) gentamicin base and betamethasone valerate equivalent to 1 mg betamethasone alcohol.
(b) Sponsors. See Nos. 000061 and 054925 in § 510.600(c) of this chapter.
(c) Conditions of use—(1) Amounts and indications for use—(i) For the treatment of acute and chronic otitis externa caused by bacteria sensitive to gentamicin in dogs, instill three to eight drops of solution into the ear canal twice daily for 7 to 14 days.
(ii) For the treatment of infected superficial lesions caused by bacteria sensitive to gentamicin in dogs and cats, apply a sufficient amount of the drug to cover the treatment area twice daily for 7 to 14 days.
14. Revise § 524.1044f to read as follows:
Gentamicin sulfate, betamethasone valerate topical spray.
(a) Specifications. Each milliliter of spray contains gentamicin sulfate equivalent to 0.57 milligram (mg) gentamicin base and betamethasone valerate equivalent to 0.284 mg betamethasone.
(c) Conditions of use in dogs—(1) Amount. Hold bottle upright 3 to 6 inches from the lesion and depress the sprayer head twice. Administer two spray actuations two to four times daily for 7 days.
(2) Indications for use. For the treatment of infected superficial lesions caused by bacteria sensitive to gentamicin.
15. In paragraph (b)(2) of § 524.1044g, remove “051259” and add in its place “054925”.
16. In paragraph (b)(2) of § 524.1193, remove “051259, 051311” and add in its place “051311, 054925”.
17. Revise § 524.1443 to read as follows:
§ 524.1443
(a) Specifications—(1) Each gram of cream contains miconazole nitrate equivalent to 20 milligrams miconazole base.
(2) Each gram of lotion or spray contains miconazole nitrate equivalent to 1 percent miconazole base.
(b) Sponsors. See § 510.600(c) of this chapter for use as in paragraph (c) of this section:
(1) No. 000061 for use of cream, lotion, and spray;
(2) Nos. 054925 and 058829 for use of lotion and spray.
(c) Conditions of use in dogs and cats—(1) Amount. Apply once daily by rubbing into or spraying a light covering on the infected site and the immediate surrounding vicinity. Continue treatment for 2 to 4 weeks until infection is completely eradicated as determined by appropriate laboratory examination.
(2) Indications for use. For topical treatment of infections caused by Microsporum canis, Microsporum gypseum, and Trichophyton mentagrophytes.
18. In paragraph (b)(1) of § 524.1580b, remove “051259” and add in its place “054925”.
§ 524.1580e
19. In paragraph (b) of § 524.1580e, remove “051259” and add in its place “054925”.
§ 524.1600a
20. In paragraph (b) of § 524.1600a, remove both occurrences of “051259, and 053501” and add in their places “053501, and 054925”.
21. Revise § 524.2481 to read as follows:
§ 524.2481
Triamcinolone cream.
(a) Specifications. The vanishing cream contains 0.1 percent triamcinolone acetonide.
(b) Sponsor. See Nos. 053501 and 054925 in § 510.600(c) of this chapter.
Start Printed Page 13543
(c) Conditions of use in dogs—(1) Amount. Rub into affected areas two to four times daily for 4 to 10 days.
(2) Indications for use. As an anti-inflammatory, antipruritic, and antiallergic agent for topical treatment of allergic dermatitis and summer eczema.
(3) Limitations. Federal law restricts this drug to use only by or on the order of a licensed veterinarian.
§ 529.1044b
23. In paragraph (b) of § 529.1044b, remove “
[FR Doc. 06-2554 Filed 3-15-06; 8:45 am]